European Cannabis Symposium Agenda

Day 1
Monday, 04 May
Registration & Exhibits Open Throughout the Day
Day 2
Tuesday, 05 May
Exhibits Open Throughout Day

Filter Agenda by Type:

Time

Sessions

10:00 - 10:05

General Sessions
Welcome

10:05 - 10:40

General Sessions
State of the Industry

10:40 - 11:20

General Sessions
Learning from the Tech Boom

11:20 - 12:00

General Sessions
The Lynchpin: European GMP and Compliance

12:00 - 13:15

LUNCH

13:15 - 13:35

General Sessions
In Focus: Denmark’s Pilot Program

13:35 - 14:20

General Sessions
Challenges of Doing Business Across an Unharmonized Market

14:20 - 15:00

General Sessions
Novel Food Directive: What It Means for Your Company

15:00 - 15:30

BREAK

15:30 - 16:10

General Sessions
Lessons Learned from North America

16:20 - 17:00

General Sessions
Breaking into Inter-European Trade

17:00 - 19:00

WELCOME RECEPTION

Time

Sessions

Speakers

09:00 - 09:40

Preparing for the Future
Production Licensing in New Markets

Aleksandar Pelovski
Chief Operating Officer , PharmaRolly

09:00 - 09:40

Opportunities in Hemp
Deep Dive: The Hemp Powerhouses

09:50 - 10:30

Preparing for the Future
Distribution Opportunities in the Emerging Markets

Andrew De Roy
Founder & Partner , Bearstone Global

09:50 - 10:30

Opportunities in Hemp
Action Items: Writing Your Novel Food Designation Application

Robert Cookson
Senior Consultant , Hanway Associates

10:30 - 11:00

BREAK

11:00 - 11:50

Opportunities in Hemp
Beyond CBD: Opportunities in Industrial Hemp

11:00 - 11:50

Preparing for the Future
Mergers and Acquisitions: How to Know When and If It’s Right for You

12:00 - 13:00

NETWORKING LUNCH

13:00 - 13:40

Industry Regulation
Profits Despite Regulation: Cultivation and Processing

Kostas Ioannou
European Team , Vitalis Extraction Technology

13:00 - 13:40

Investing and Raising Capital
Investing Beyond Borders

Brian Mertz
Founder , Medican

13:50 - 14:30

Industry Regulation
Exploring Canadian Opportunities

13:50 - 14:30

Investing and Raising Capital
Steps to Raising Capital

Rick Brar
Chair & CEO , Brains Bioceutical

14:30 - 15:00

BREAK

15:00 - 15:50

Industry Regulation
Case Study: The Success of the German Market

Benedikt Sons
CEO & Co-founder , Cansativa GmbH

Linus Maximilian Weber
Founder & CEO , Nimbus Health

Hendrik Knopp
Managing Director , Aphria Germany

15:00 - 15:50

Investing and Raising Capital
What to Watch for: Cannabis Investing in Europe

Narbé Alexandrian
President & CEO , Canopy Rivers

William Muecke
Managing Member , Artemis Growth Partners

16:00 - 17:30

CLOSING RECEPTION